IP Verse

Treatment Of Lag-3 Positive Tumors

Patent No. EP3631454 (titled "Treatment Of Lag-3 Positive Tumors") was filed by Bristol Myers Squibb on May 30, 2018. The application was issued on Sep 13, 2023.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
REGENERON PHARMACEUTICALSJun 13, 2024COHAUSZ & FLORACK
ROTHJun 3, 2024KONIG SZYNKA TILMANN VON RENESSE PATENTANWALTE PARTNERSCHAFT MBB DUSSELDORF

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3631454

BRISTOL MYERS SQUIBB
Application Number
EP18735009A
Filing Date
May 30, 2018
Status
Granted And Under Opposition
Aug 11, 2023
Publication Date
Sep 13, 2023
External Links
Slate, Register , Google Patents